ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Scientific Director, Pharmaceutical Development Analytics at Neurocrine Biosciences - ApplyBlast

Scientific Director, Pharmaceutical Development Analytics

Neurocrine Biosciences

2 months ago

3.7 on Glassdoor

San Diego, California, United States

Onsite

Full Time

Director

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Scientific Director, Pharmaceutical Development Analytics is a senior technical individual contributor who leads quantitative and statistical efforts across the drug product development lifecycle. Embedded within Manufacturing, Science & Technology, the role applies advanced analytics to improve formulation performance, process robustness, and regulatory submissions, partnering with cross‑functional teams to translate complex data into actionable insights.

Responsibilities

Lead portfolio-level statistical and quantitative science initiatives
Design and apply advanced statistical methods to support formulation and process development
Serve as quantitative lead for CMC regulatory submissions and lifecycle management

Skills

Qualifications

Bachelor's degree in Chemical EngineeringMaster's degree in Chemical EngineeringPhD in Chemical Engineering

About Neurocrine Biosciences

neurocrine.com

Headquarters

San Diego, California, United States

Company Size

1001-5000 employees

Founded

1992

View Profile

Neurocrine Biosciences is a biopharmaceutical company focused on discovering and developing treatments for patients with neurological, psychiatric, endocrine, and immunological disorders. With over 30 years of research, the company works to bring hope to people living with rare diseases and conditions that lack viable treatment options. Neurocrine develops and markets approved medicines while maintaining an active clinical pipeline across multiple therapeutic areas.